Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Liabilities and Shareholders Equity (2016 - 2025)

Stemtech's Liabilities and Shareholders Equity history spans 6 years, with the latest figure at $3.8 million for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity changed N/A to $3.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $15.2 million, a 38.04% increase, with the full-year FY2024 number at $3.8 million, up 2.69% from a year prior.
  • Liabilities and Shareholders Equity hit $3.8 million in Q3 2025 for Stemtech, down from $3.9 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for STEK hit a ceiling of $6.3 million in Q3 2021 and a floor of $3.6 million in Q1 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $4.4 million across 5 years, with a median of $4.2 million in 2022.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 14.19% in 2021 and later tumbled 30.68% in 2022.
  • Tracing STEK's Liabilities and Shareholders Equity over 5 years: stood at $5.7 million in 2021, then fell by 25.4% to $4.3 million in 2022, then fell by 13.68% to $3.7 million in 2023, then rose by 2.69% to $3.8 million in 2024, then decreased by 0.7% to $3.8 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for STEK at $3.8 million in Q3 2025, $3.9 million in Q2 2025, and $3.8 million in Q1 2025.